BioAtla, Inc.BCABNASDAQ
LOADING
|||
Switch Symbol:
Analysts lean bullish — 67% recommend buying.
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Analysts see significant upside — consensus target 2546% higher.
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.